Your browser doesn't support JavaScript. Please upgrade to a modern browser or enable JavaScript in your existing browser.
Skip Navigation U.S. Department of Health and Human Services www.hhs.gov
Agency for Healthcare Research Quality www.ahrq.gov
www.ahrq.gov


Appendix Table. Inclusion and Exclusion Criteria According to Key Question *

Question Criteria
KQ 1, 2a, 3
(risk assessment)
Include

Risk models
Risk evaluation instrument
Practice standards or guidelines
Randomized, controlled trial
Comparative study (cohort, case-control, or observational study) with >50 participants
Overview, meta-analysis, or review with relevant information
Cost

Exclude

Not applicable to U.S. primary care setting
Study limitations (small number of participants, noncomparative, single case report)
No data (commentary, letter, opinion)
Information not relevant (dated, off-topic)

KQ 1, 2b, 3
(genetic counseling)
Include

Randomized, controlled trial
Comparative study (cohort, case-control, or observational study) with >50 participants
Overview, meta-analysis, or review with relevant information
Practice standards or guidelines
Cost

Exclude

Not applicable to U.S. primary care setting
Study limitations (small number of participants, noncomparative, single case report)
No data (commentary, letter, opinion)
Information not relevant (dated, off-topic)

KQ 1, 2c, 3
(genetic testing)
Include

Genetic testing for heritable clinically significant BRCA1 and/or BRCA2 mutations (excludes studies of tumor tissue only)
Participants from United States, Canada, United Kingdom, Australia, or Israel >50 participants

Exclude

Risk model only
No primary data included (include meta-analysis)
Not BRCA1 or BRCA2
Not breast or ovarian cancer
No genetic testing
Only second cancer at same site (risk for second, contralateral cancer)
Basic science only (studies of gene function or gene expression)
Tumor tissue only
Linkage and/or segregation analysis (i.e., no testing for BRCA1 or BRCA2 mutations)

KQ 4 and KQ 5
(interventions and adverse effects)
Include

Randomized, controlled trial
Comparative study (cohort, case-control, or observational study) with >50 participants
Overview, meta-analysis, or review with relevant information
Surveillance
Chemoprevention
Prophylactic surgery
Cost

Exclude

Not applicable to U.S. primary care setting
Study limitations (small number of participants, noncomparative, single case report)
No data (commentary, letter, opinion)
Information not relevant (dated, off-topic)

* KQ = key question.

Return to Document

 

AHRQ Advancing Excellence in Health Care